EMD Serono, a biopharmaceutical business operating under Merck KGaA in Darmstadt, Germany, recently announced that it has received CEO Cancer Gold Standard re-accreditation for its dedication to employee health.
The company was able to meet the latest comprehensive requirements that are outlined in the national workplace wellness accreditation program from the CEO Roundtable on Cancer, established by former U.S. President George Bush Senior.
The CEO Roundtable on Cancer unites important cancer leaders from businesses, the government, nonprofit sectors and academic industries. In turn, they exchange ideas to develop and apply initiatives to decrease the risk of cancer, promote the best available treatments, encourage early diagnosis and urge scientists to discover new anti-cancer therapies and treatments.
“Nearly all of us are impacted by cancer in some way,” Gary Zieziula, president and managing director for North America, said. “At EMD Serono, we are committed to making a difference in the lives of patients, their loved ones and health care professionals by accelerating innovation in oncology in order to develop therapies with the potential to transform the way cancer is treated. This commitment extends to our corporate family through employee wellness programs that are designed to help reduce the risk of cancer, promote early detection and provide quality care.”
